Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Silverman

Showing results (801-810 of 816) with videos related to

Pageof 82
Sort By:
Pediatric Blood & Cancer|February 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium TrialNirali N Shah, Eric S Schafer, Yueh-Yun Chi, et al.
The Lancet. Oncology|November 10, 2015
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trialAndrew E Place, Kristen E Stevenson, Lynda M Vrooman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622William B Slayton, Kirk R Schultz, John A Kairalla, et al.
Cancer Discovery|October 5, 2017
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic LeukemiaRiadh Lobbardi, Jordan Pinder, Barbara Martinez-Pastor, et al.
Pediatric Blood & Cancer|October 7, 2020
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001Melissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Leukemia|April 12, 2003
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsC-H Pui, J M Chessells, B Camitta, et al.
Pediatric Blood & Cancer|January 28, 2021
CorrigendumMelissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Iscience|January 11, 2024
From <i>Tg</i>O/GABA-AT, GABA, and T-263 Mutant to Conception of <i>Toxoplasma</i>Joseph Lykins, Matthew J Moschitto, Ying Zhou, et al.
The Journal of Experimental Medicine|November 9, 2018
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemiaIngrid M Ariës, Kimberly Bodaar, Salmaan A Karim, et al.
Nature Genetics|April 22, 2014
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylationAndrew A Lane, Bjoern Chapuy, Charles Y Lin, et al.
Pageof 82

Showing results (801-810 of 816) with videos related to

Sort By:
Pageof 82
Pediatric Blood & Cancer|February 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium TrialNirali N Shah, Eric S Schafer, Yueh-Yun Chi, et al.
The Lancet. Oncology|November 10, 2015
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trialAndrew E Place, Kristen E Stevenson, Lynda M Vrooman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622William B Slayton, Kirk R Schultz, John A Kairalla, et al.
Cancer Discovery|October 5, 2017
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic LeukemiaRiadh Lobbardi, Jordan Pinder, Barbara Martinez-Pastor, et al.
Pediatric Blood & Cancer|October 7, 2020
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001Melissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Leukemia|April 12, 2003
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangementsC-H Pui, J M Chessells, B Camitta, et al.
Pediatric Blood & Cancer|January 28, 2021
CorrigendumMelissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Iscience|January 11, 2024
From <i>Tg</i>O/GABA-AT, GABA, and T-263 Mutant to Conception of <i>Toxoplasma</i>Joseph Lykins, Matthew J Moschitto, Ying Zhou, et al.
The Journal of Experimental Medicine|November 9, 2018
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemiaIngrid M Ariës, Kimberly Bodaar, Salmaan A Karim, et al.
Nature Genetics|April 22, 2014
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylationAndrew A Lane, Bjoern Chapuy, Charles Y Lin, et al.
Pageof 82